cyclosporine

Key facts

INN

cyclosporine

Brand

RESTASIS

Route

OPHTHALMIC

Formulation

EMULSION

Originator

Amneal Pharmaceuticals

Related patents

patent

US 12409206

Use of cyclosporine analogues for treating fibrosis

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10472394

Cyclosporine analogue mixtures and their use as immunomodulating agents

Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9765119

Cyclosporine analogue mixtures and their use as immunomodulating agents

Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 7521421

Deuterated cyclosporine analogs and methods of making the same

Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 7332472

Cyclosporine analogue mixtures and their use as immunomodulating agents

Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6998385

Cyclosporine analogue mixtures and their use as immunomodulating agents

Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6686454

Antibodies to specific regions of cyclosporine related compounds

Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6613739

Deuterated cyclosporine analogs and their use as immunomodulating agents

Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is cyclosporine?

cyclosporine (RESTASIS), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for cyclosporine?

RESTASIS is a marketed brand name for cyclosporine. Check FDA Drugs@FDA for the current US label holder.